Civic Intelligence

The Foundation for Embryonic Competence Inc.

990 • Fiscal year 2013 • EIN 46-3032063

Oct 01, 2012 to Sep 30, 2013

Basking Ridge, NJ
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

99th percentile

1.00x

Higher debt load relative to assets than 99% of similar nonprofits.

2013 filings • NTEE H • <$500k nonprofits • Source year 2013

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2013

Net Margin

Score unavailable

No value available

Net margin requires both revenue and expenses on this filing.

Source year 2013

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2013

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

$414,217

No earlier filing loaded for comparison.

Net Assets

-$131

No earlier filing loaded for comparison.

Liabilities

$414,348

No earlier filing loaded for comparison.

Revenue

$0

No earlier filing loaded for comparison.

Expenses

$131

No earlier filing loaded for comparison.

Net Income

-$131

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0-$50MAssets 2013: $414,217Liabilities 2013: $414,348Net Assets 2013: -$1312013Assets 2014: $91,626,123Liabilities 2014: $860,633Net Assets 2014: $90,765,4902014Assets 2015: $93,972,721Liabilities 2015: $1,191,474Net Assets 2015: $92,781,2472015Assets 2016: $95,139,687Liabilities 2016: $566,861Net Assets 2016: $94,572,8262016Assets 2017: $22,887,313Liabilities 2017: $517,970Net Assets 2017: $22,369,3432017Assets 2018: $23,560,103Liabilities 2018: $1,820,682Net Assets 2018: $21,739,4212018Assets 2019: $21,003,256Liabilities 2019: $1,150,029Net Assets 2019: $19,853,2272019Assets 2020: $20,006,242Liabilities 2020: $1,275,666Net Assets 2020: $18,730,5762020Assets 2021: $27,223,706Liabilities 2021: $914,946Net Assets 2021: $26,308,7602021Assets 2022: $16,430,730Liabilities 2022: $365,526Net Assets 2022: $16,065,2042022Assets 2023: $14,752,429Liabilities 2023: $165,446Net Assets 2023: $14,586,9832023Assets 2024: $13,627,794Liabilities 2024: $158,676Net Assets 2024: $13,469,1182024

Highlighted filing

2013

Assets$414,217
Liabilities$414,348
Net Assets-$131

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100M$50M$0-$50M-$100MRevenue 2013: $0Expenses 2013: $131Net Income 2013: -$1312013Revenue 2014: $94,632,976Expenses 2014: $3,830,619Net Income 2014: $90,802,3572014Revenue 2015: $9,684,125Expenses 2015: $7,478,668Net Income 2015: $2,205,4572015Revenue 2016: $9,631,499Expenses 2016: $8,079,084Net Income 2016: $1,552,4152016Revenue 2017: $8,966,143Expenses 2017: $77,414,549Net Income 2017: -$68,448,4062017Revenue 2018: $5,963,159Expenses 2018: $6,568,585Net Income 2018: -$605,4262018Revenue 2019: $5,872,571Expenses 2019: $7,812,065Net Income 2019: -$1,939,4942019Revenue 2020: $5,787,769Expenses 2020: $6,938,014Net Income 2020: -$1,150,2452020Revenue 2021: $15,272,541Expenses 2021: $8,009,129Net Income 2021: $7,263,4122021Revenue 2022: $7,260,831Expenses 2022: $4,653,715Net Income 2022: $2,607,1162022Revenue 2023: -$3,532,420Expenses 2023: $1,387,565Net Income 2023: -$4,919,9852023Revenue 2024: $60,778Expenses 2024: $1,351,782Net Income 2024: -$1,291,0042024

Highlighted filing

2013

Revenue$0
Expenses$131
Net Income-$131
Filing Detail Status

This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Oct 1, 2012 to Sep 30, 2013
Mission and Program Overview

Mission

Technology (art) clinics.providing broad access to single gene disorder diagnostics so that individual with a known genetic condition can have their embryos evaluated to improve their likelihood of having a baby who is not affected by the genetic conditionsponsoring research that advances the field of embryonic competence and provides a clear pathway to improved clinical outcomes and reduced complications for ivf pateints.supporting continuing medical education (cme), graduate-level educational initiatives, and other educational activities to advance our understanding and the application of embryonic diagnostics around the world.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings